-
Gatekeepers of Science: Evolving Publishing Policies in the Age of AI
Sep 9, 2025, 16:22 PM -
Generalizability of a Randomized Clinical Trial-Based Prediction Model in a Real-World Population
Sep 9, 2025, 16:22 PM -
What Is Required for "Disease-Modifying Therapy" Value Perception From Leading HTA?
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis for an Efficacy Assessment of Avelumab Axitinib in the First-Line Treatment of International Metastatic RCC Database Consortium (IMDC) Favorable Risk Patients With Advanced Renal Cell Carcinoma (ARCC)
Sep 9, 2025, 16:22 PM -
Multimorbidity and Health-Related Quality of Life Among Adult Population in the United States
Sep 9, 2025, 16:22 PM -
Qualitative Assessment of Women’s Experiences of Sleep Disturbances Associated With Menopause to Evaluate Content Validity of Patient-Reported Outcomes
Sep 9, 2025, 16:22 PM -
Multinational Qualitative Testing of the Experimental EuroQol Toddler and Infant Populations (EQ-TIPS) Instrument
Sep 9, 2025, 16:22 PM -
Impact of RFID-Enabled Unit-Level Traceability on Resource Utilization and Quality Assurance in Prefilled Syringe Production
Sep 9, 2025, 16:22 PM -
From License to Reimbursement: A Slot-Based ML Framework for Seamless MA to HTA Alignment
Sep 9, 2025, 16:22 PM -
Improving Identification of Patients With Rare Diseases Through Indirect Linkage Between French Medico-Administrative Claims Database (SNDS) and National Rare Disease Registry (BNDMR) in France: A Dual-Population Study
Sep 9, 2025, 16:22 PM -
Patient Involvement in the Development of Obesity and Weight Loss-Specific Patient-Reported Outcome Measures
Sep 9, 2025, 16:22 PM -
Novel Adverse Events of Trastuzumab: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Sep 9, 2025, 16:22 PM -
Are Anti-Obesity Drugs Life-Saving or Lifestyle Medicines? Reframing the Policy and Economic Debate
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of High-Dose vs. Adjuvanted Trivalent Influenza Vaccines in Older Adults in Korea
Sep 9, 2025, 16:22 PM -
Overview Of Reimbursement Status Of Disease-Modifying Therapies In EU4+UK Over The Past 3 Years And Upcoming Drugs
Sep 9, 2025, 16:22 PM -
Valuing the Invisible: Societal Costs of Alzheimer’s Disease From a Malaysian Perspective
Sep 9, 2025, 16:22 PM -
Reevaluating Cost-Effectiveness: A Holistic Framework for Assessing Disease-Modifying Treatments in Type 1 Diabetes
Sep 9, 2025, 16:22 PM -
A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research
Sep 9, 2025, 16:22 PM -
Improving Patient Flow and Multidisciplinary Coordination in Urothelial Carcinoma: Insights From Bulgarian Oncologists
Sep 9, 2025, 16:22 PM -
Are Glucagon-Like Peptide-1 Receptor Agonists Prescribed for Weight Loss Slipping Through the Net of Japan’s Strict Guidelines? An Analysis of Health Insurance Claims Data
Sep 9, 2025, 16:22 PM